NK Cell Therapy for Malignant Solid Brain Tumors

Clinical trial NCT07552233 · RECRUITING

Trial details

NCT number: NCT07552233
Sponsor: Peking University Third Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Malignant Solid Brain Tumors Glioblastoma (GBM)Glioblastoma Multiforme (GBM)Brain Metastasis Malignant Meningioma

Start date: 2026-04-01
Primary completion: 2030-12-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.